Med Ed Report briefs: December 2013

Risperdal
Risperdal

Bayer Healthcare, Onyx Pharmceuticals and Lilly sponsored a CME workshop series for oncologists and oncology nurses, offering guidance on treatment of solid tumors. ACCME-accredited firm Med-IQ is the provider on the presentations.

The probe that resulted in J&J's $2.2-billion settlement last month for alleged illegal marketing of Risperdal and other drugs also named several academic medical centers. ­According to the Chronicle of Higher Education, the probe fingered a list of more than 50 researchers at some two dozen mostly US universities who wrote articles for medical journals that J&J allegedly used to overstate the benefits and understate the risks of the drug.

CMS updated its frequently asked questions page on the Open Payments program—formerly known as the Physician Payment Sunshine Act, noted the blog Policy and Medicine. The page was updated with 20 new FAQs.

Community Care Behavioral Health Organization said it's offering a series of 12 web-based trainings for psychiatrists focusing on strategies to help improve health. The 30-minute presentations each come with free CME credits.

You must be a registered member of MMM to post a comment.

Email Newsletters


As US pharma continued its quest for a Grand Prix at the Lions Health international festival of creativity, MM&M went on location to Cannes, France. Missed our coverage from June? Now, we're giving you an opportunity to catch up on some of what you missed. Download our e-book on the two-day festival, recapping the event, rounding up the best of the speakers, offering perspective and listing all of the winners. Click here to download.


The most recent MM&M Skill Sets Live event surveyed a range of issues relating to one of the hottest promotional spaces in healthcare. Speakers and panelists at the morning-long session, including promotional- and multichannel-minded executives from GSK, Epocrates, Treato and Montefiore Medical Center, weighed in on topics designed to help marketers demystify the challenges associated with non-personal promotion. Click here.